HSF Advises on the HK$3.97 Billion IPO of Fosun Pharma

Wednesday, October 31, 2012

Herbert Smith Freehills has advised UBS AG, China International Capital Corporation, J.P. Morgan Securities (Asia Pacific) Limited, Deutsche Bank AG, Agricultural Bank of China International and Haitong International as underwriters on the HK$3.97 billion (US$509 million) initial public offering (IPO) of Shanghai Fosun Pharmaceutical Group Co. Ltd (“Fosun Pharma”) on the main board of the Hong Kong Stock Exchange and Rule 144A/Regulation S global offering on 30 October, 2012. The deal marks one of the largest IPOs in the world’s pharmaceutical industry since June 2011 and one of the few recent significant new listings in Hong Kong since July this year.

More >>

Tags:  Herbert Smith Freehills Kramer LLP | Hong Kong

CMS Advises on £696 Million Sale of Horizon Nuclear Power

Wednesday, October 31, 2012

CMS has advised RWE in relation to the sale of Horizon Nuclear Power for £696 million. Horizon Nuclear Power is a UK energy company created to develop a new generation of nuclear power stations. It was formed as a joint venture by E.ON and RWE in 2009, but in March 2012, following a strategic review, the companies announced they would not proceed and would instead look to find a new owner.

More >>

Tags:  CMS

DLA Piper Strengthens Real Estate Practice with the Hire of Two Construction Partners

Wednesday, October 31, 2012

DLA Piper announces today the hire of two partners, Mark Hilton and Simon Palmer, to join its Real Estate Group as part of the construction and engineering practice, specialising in dispute resolution. They will also work closely with the Litigation & Regulatory Group. Both Mark and Simon join from Addleshaw Goddard where Mark is Head of Contentious Construction. Mark will work out of the London office and Simon will work out of the Sheffield office.

More >>

Tags:  DLA Piper